Accueil Products

VEDA.LAB S.A., a privately owned company founded in 1991, by Dr Donati and Mr Stankov,specialises in R&D and the production of rapid immunochromatographic tests and kits.

We are focusing on international expansion through the formation of strategic alliances and partnerships with distributors worldwide. We are one of the largest European certified companies involved in rapid medical diagnostic tests and kits.

Our headquaters, R&D and manufacturing resources are located in an ultramodern ISO 9001- and ISO 13485 -accredited facility on the outskirts of the nice French city of ALENCON.

VEDA.LAB occupies 3000 m2 of modern R&D and manufacturing facilities and employs about 50 people who focus on designing, developing, producing and marketing a wide range of innovative products with patented technologies.

VEDA.LAB has targeted its research and development resources on technological applications in immunology, primarily in the area of in-vitro diagnostics, and, thanks to the company's people, entrepreneurial spirit and a tremendous amount of hard work, VEDA.LAB has managed to achieve exemplary growth in the industry. VEDA.LAB is now a reference in the field of rapid diagnostics worldwide.

VEDA.LAB' s major developments are as follows :

2011 Lyme CE mark for home use
IgE CE mark for home use
INSULIN quantitative test for the rapid test reader
FSH quantitative test for the rapid test reader
2010

Ferritin CE mark for home use
H. Pylori CE mark for home use
TSH CE mark for home use
CA-125 quantitative test for the rapid test reader
Microalbumin quantitative test for the rapid test reader
Quality system accreditation (CMDCAS) in Canada : ISO 13485 : 2003.

2009 FOB quantitative test for the rapid test reader.
EN ISO 9001 (2008) - EN ISO 13485 (2003) Certification obtained from MDC GmbH notified body.
2008
CK-MB quantitative test for the rapid test reader.
hCG quantitative test for the rapid test reader.
HEM CE mark for home use (POLY-CHECK ®).
2007
IgE quantitative test for the rapid test reader.
New product development (Influenza A and B, C.d.Toxin B, Lyme IgG and IgM)
PSA CE mark for home use.
CEA quantitative test for the rapid test reader.
PROLACTIN quantitative test for the rapid test reader.
AFP quantitative test for the rapid test reader.
2006
FERRITIN quantitative test for the rapid test reader.
MYOGLOBIN quantitative test for the rapid test reader.
New product development (Chagas).
Departure of Milovan STANKOV.
Patent litigation settlement.
2005
NF EN ISO 13485 : 2004 certification obtained from LNE/GMED (French notified body).
VEDA.LAB rapid test reader (EASY READER®),
PSA semi-quantitative and quantitative determination for the rapid test reader
TROPONIN I quantitative determination for the rapid test reader
TSH quantitative determination for the rapid test reader
URICHECK biochemistry strips.
2004
Quality system management approved on the basis of ISO 9001 : 2000 and ISO 13485 : 2001 standards.
New products developed.
2003


Full application of European IVD 98/79 CE requirements.
GMP (EN 46001) certification renewal of the QA system by G-MED (French notified Body).
New products development.
Launch of a rapid test reader optimised for PSA rapid test quantitative results reading.

2002

Automation of production (2nd stage).
Compliance with CE requirements.
New products developed

2001


Celebration of the 10th anniversary of the company's creation.
CE marking of "Baby Check" and "Evidence" pregnancy tests.
Construction of the third phase of the GMP facility.
New products developed

2000

Application of European IV 98/79CE.
Extension of the QA certificate as per GMP (EN46001).

1999

QA System certified by the French QA association (AFAQ)
New products developed (ADENO, ROTA, RSV).

1998

Automation of production (1st stage).

1997

Construction (extension) of the second phase of the GMP facility.

1996

New VEDA.LAB products developed in-house (cardiac markers, DOA, TB and Syphilis) were launched on the international market.

1995

Set-up of the Quality Assurance system (QA) in compliance with ISO 9001 standards.
Development of veterinary rapid tests (FEV, FELV).

 1994

Construction of the first phase of a new GMP facility

 1993

FDA approval of pregnancy test in USA (510 k)
Export of rapid tests to India, China, Russia and Latin America

1992 Product launch on the US market
Development of other fertility (LH, FSH) and infectious disease rapid tests (Chlamydia and Strep A).
1991 Foundation of the company by Mr STANKOV and Dr DONATI
Launch of the Baby Check pregnancy test in FRANCE and EUROPE.